Login/Sign Up
MRP ₹43760.5
(Inclusive of all Taxes)
₹5251.3 Cashback (12%)
Lynparza 150Mg Tablet is used to treat various cancers, including ovarian, breast, pancreatic, and prostate. It contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage. Avoid taking this medication if you are pregnant or breastfeeding because this can cause harmful effects on the unborn baby. Both women and men using this should use birth control to avoid pregnancy.
Provide Delivery Location
About Lynparza 150Mg Tablet
Lynparza 150Mg Tablet is an 'anti-cancer' drug used to treat various cancers, including ovarian, breast, pancreatic, and prostate. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs.
Lynparza 150Mg Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
Use this medicine as directed by your doctor. You may sometimes experience shortness of breath (dyspnoea), feeling very tired, pale skin or fast heartbeat, anaemia, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Most of these side effects may gradually resolve over time. However, if the side effects persist or worsen, consult your doctor.
To treat your condition effectually, continue taking Lynparza 150Mg Tablet for as long as your doctor has prescribed. Do not stop using the Lynparza 150Mg Tablet midway. Talk to your doctor before taking Lynparza 150Mg Tablet if you have severe allergic reactions to Lynparza 150Mg Tablet or other medicines or suffer from severe infections, renal dysfunction, hepatic disorders and blood cell counts are too low. Avoid taking Lynparza 150Mg Tablet if you are pregnant or breastfeeding because this Lynparza 150Mg Tablet can cause harmful effects on the unborn baby. Both women and men using this Lynparza 150Mg Tablet should use birth control to avoid pregnancy. While on Lynparza 150Mg Tablet treatment, you should avoid eating grapefruit, Seville oranges or consuming grapefruit juice since it can affect how the medicine works.
Uses of Lynparza 150Mg Tablet
Lynparza 150Mg Tablet is used in the treatment of Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. The detailed uses of Lynparza 150Mg Tablet are as follows:
Have a query?
Directions for Use
Medicinal Benefits
Lynparza 150Mg Tablet belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate. Lynparza 150Mg Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
How Lynparza 150Mg Tablet Works
Storage
What if I have taken an overdose of Lynparza 150Mg Tablet
Drug Warnings
Always take this medicine exactly as your doctor or healthcare professional has told you. To treat your condition effectually, continue taking Lynparza 150Mg Tablet for as long as your doctor has prescribed. Do not stop Lynparza 150Mg Tablet midway. Talk to your doctor before taking Lynparza 150Mg Tablet if you have severe allergic reactions to Lynparza 150Mg Tablet or other medicines or suffer from any medical illness. Avoid taking Lynparza 150Mg Tablet if you are pregnant or breastfeeding because this Lynparza 150Mg Tablet can cause harmful effects on the unborn baby. Both women and men using this Lynparza 150Mg Tablet should use birth control to avoid pregnancy. Do not start Lynparza 150Mg Tablet unless patients have recovered from haematological damage induced by previous chemotherapy (Grade 1). Check full blood count for cytopenia at baseline and monthly afterwards for clinically significant changes during treatment. For persistent haematological toxicity, discontinue Lynparza 150Mg Tablet and monitor blood count weekly until recovery. Do not receive any immunization or vaccination without your doctor's approval while taking the Lynparza 150Mg Tablet.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
Avoid alcohol consumption while on treatment with Lynparza 150Mg Tablet.
Pregnancy
Unsafe
Lynparza 150Mg Tablet should not be used during pregnancy because it can harm your fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking Lynparza 150Mg Tablet and at least for six months later treatment. Your doctor will weigh the benefits and risks before prescribing this medicine.
Breast Feeding
Unsafe
Do not breastfeed during this treatment because the medicine may pass into your milk. Doctors normally advise against breastfeeding throughout this treatment and for one month after the final medication is taken.
Driving
Caution
Lynparza 150Mg Tablet may affect your reactions and your ability to drive. Do not drive and/or operate machines that require your alertness.
Liver
Caution
In patients with mild or moderate liver impairment, there is no need to alter the initial dose. There is no information available on patients with severe liver impairment.
Kidney
Caution
In patients with mild or moderate kidney impairment, there is no need to alter the initial dose. There is no information available on patients with severe kidney impairment.
Children
Caution
The safety and effectiveness of Lynparza 150Mg Tablet in pediatric patients have not been established.
Heart
Please consult your doctor before receiving Lynparza 150Mg Tablet if you have pre-existing heart problems. Your doctor will prescribe Lynparza 150Mg Tablet if the benefits outweigh the risks.
Geriatrics
Consult your doctor
Please consult a doctor before administering Lynparza 150Mg Tablet to geriatric patients. Your doctor will prescribe Lynparza 150Mg Tablet if the benefits outweigh the risks.
Lynparza 150Mg Tablet is used to treat ovarian, breast, pancreatic, and prostate cancers.
Lynparza 150Mg Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
If you are allergic to Olaparib or any other ingredients in this medication, are breastfeeding, or have too low blood cell counts, you should not use Lynparza 150Mg Tablet.
Yes, Lynparza 150Mg Tablet can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or have an infection.
Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.
Lynparza 150Mg Tablet is not a traditional chemotherapy pill. It's a targeted therapy, also known as a PARP inhibitor, which works differently from chemotherapy.
When taking Lynparza 150Mg Tablet, avoid or limit foods high in grapefruit or grapefruit juice, as these can interact with the medication. Additionally, consult your doctor or pharmacist for personalized dietary advice.
The duration of Lynparza 150Mg Tablet treatment can vary depending on the type of cancer being treated and the patient's response to the medication. Generally, Lynparza 150Mg Tablet is taken until disease progression, unacceptable toxicity, or completion of a specified treatment period. Therefore, follow your doctor's instructions carefully.
Before taking Lynparza 150Mg Tablet, inform your doctor about all your medical conditions, sensitivities, and medications. Also, mention if you're pregnant, planning to become pregnant, or breastfeeding. This will ensure safe use and help avoid any potential interactions.
Lynparza 150Mg Tablet can interact with other medications, so do not use any other medications unless your doctor advises. Your doctor will check for potential interactions and advise you on how to take them safely with Lynparza 150Mg Tablet.
No, Lynparza 150Mg Tablet is not recommended for use during pregnancy and breastfeeding, and it causes unwanted side effects. However, please consult your doctor if you have any concerns.
The common side effects of Lynparza 150Mg Tablet are feeling very tired, pale skin, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Please consult your doctor if any of these side effects persist or worsen.
Country of origin
Manufacturer/Marketer address
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd